Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D E WILCKEN

Showing results (111-120 of 151) with videos related to

Pageof 16
Sort By:
The Journal of Laboratory and Clinical Medicine|January 1, 1971
The inhibition of adenosine phosphorylation in platelets by dipyridamoleM C Rozenberg, C M Ledwidge, D E Wilcken, et al.
Lancet (London, England)|August 15, 1992
Changes of allele-specific expression of apo(a) gene in infants during first year of lifeX L Wang, D E Wilcken, N P Dudman, et al.
The Biochemical Journal|April 15, 1984
Collagen composition of normal and myxomatous human mitral heart valvesW G Cole, D Chan, A J Hickey, et al.
Clinical Chemistry|October 1, 1989
Mechanisms responsible for increasing immunoreactivity of apolipoprotein A-I with storage: the role of oxidationX L Wang, N P Dudman, J Wang, et al.
The Journal of Clinical Investigation|July 15, 1996
Polymorphisms at the 5'-end of the apolipoprotein AI gene and severity of coronary artery diseaseX L Wang, S X Liu, R M McCredie, et al.
The Medical Journal of Australia|March 19, 1977
The clinical applications of two-dimensional echocardiographyD E Wilcken, H J Paoloni, M Dadd, et al.
British Heart Journal|December 1, 1986
Smoking: a major predictor of left ventricular function after occlusion of the left anterior descending coronary arteryW B McKenzie, R M McCredie, C A McGilchrist, et al.
Journal of the American College of Cardiology|June 1, 1985
Primary (spontaneous) chordal rupture: relation to myxomatous valve disease and mitral valve prolapseA J Hickey, D E Wilcken, J S Wright, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 1, 1996
Distribution in healthy and coronary populations of the methylenetetrahydrofolate reductase (MTHFR) C677T mutationD E Wilcken, X L Wang, A S Sim, et al.
Metabolism: Clinical and Experimental|October 1, 1996
Insulin-like growth factor-I decreases serum lipoprotein (a) during long-term treatment of patients with Laron syndromeZ Laron, X L Wang, B Klinger, et al.
Pageof 16

Showing results (111-120 of 151) with videos related to

Sort By:
Pageof 16
The Journal of Laboratory and Clinical Medicine|January 1, 1971
The inhibition of adenosine phosphorylation in platelets by dipyridamoleM C Rozenberg, C M Ledwidge, D E Wilcken, et al.
Lancet (London, England)|August 15, 1992
Changes of allele-specific expression of apo(a) gene in infants during first year of lifeX L Wang, D E Wilcken, N P Dudman, et al.
The Biochemical Journal|April 15, 1984
Collagen composition of normal and myxomatous human mitral heart valvesW G Cole, D Chan, A J Hickey, et al.
Clinical Chemistry|October 1, 1989
Mechanisms responsible for increasing immunoreactivity of apolipoprotein A-I with storage: the role of oxidationX L Wang, N P Dudman, J Wang, et al.
The Journal of Clinical Investigation|July 15, 1996
Polymorphisms at the 5'-end of the apolipoprotein AI gene and severity of coronary artery diseaseX L Wang, S X Liu, R M McCredie, et al.
The Medical Journal of Australia|March 19, 1977
The clinical applications of two-dimensional echocardiographyD E Wilcken, H J Paoloni, M Dadd, et al.
British Heart Journal|December 1, 1986
Smoking: a major predictor of left ventricular function after occlusion of the left anterior descending coronary arteryW B McKenzie, R M McCredie, C A McGilchrist, et al.
Journal of the American College of Cardiology|June 1, 1985
Primary (spontaneous) chordal rupture: relation to myxomatous valve disease and mitral valve prolapseA J Hickey, D E Wilcken, J S Wright, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 1, 1996
Distribution in healthy and coronary populations of the methylenetetrahydrofolate reductase (MTHFR) C677T mutationD E Wilcken, X L Wang, A S Sim, et al.
Metabolism: Clinical and Experimental|October 1, 1996
Insulin-like growth factor-I decreases serum lipoprotein (a) during long-term treatment of patients with Laron syndromeZ Laron, X L Wang, B Klinger, et al.
Pageof 16